WallStSmart

Cardinal Health Inc (CAH)vsEmpro Group Inc. Ordinary shares (EMPG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cardinal Health Inc generates 4460910% more annual revenue ($244.67B vs $5.48M). EMPG leads profitability with a 13.7% profit margin vs 0.7%. CAH trades at a lower P/E of 29.8x. CAH earns a higher WallStSmart Score of 53/100 (C-).

CAH

Buy

53

out of 100

Grade: C-

Growth: 7.3Profit: 4.5Value: 8.7Quality: 5.8
Piotroski: 4/9Altman Z: 4.30

EMPG

Hold

47

out of 100

Grade: D+

Growth: 5.3Profit: 9.0Value: 3.0Quality: 8.5
Piotroski: 6/9Altman Z: 3.11
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CAHUndervalued (+14.8%)

Margin of Safety

+14.8%

Fair Value

$263.37

Current Price

$211.31

$52.06 discount

UndervaluedFair: $263.37Overvalued
EMPGSignificantly Overvalued (-2745.9%)

Margin of Safety

-2745.9%

Fair Value

$0.61

Current Price

$17.36

$16.75 premium

UndervaluedFair: $0.61Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CAH2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.3010/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
18.8%8/10

18.8% revenue growth

EMPG4 strengths · Avg: 10.0/10
Return on EquityProfitability
66.3%10/10

Every $100 of equity generates 66 in profit

Operating MarginProfitability
36.1%10/10

Strong operational efficiency at 36.1%

Revenue GrowthGrowth
141.6%10/10

Revenue surging 141.6% year-over-year

Altman Z-ScoreHealth
3.1110/10

Safe zone — low bankruptcy risk

Areas to Watch

CAH4 concerns · Avg: 3.3/10
P/E RatioValuation
29.8x4/10

Moderate valuation

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.7%3/10

0.7% margin — thin

Operating MarginProfitability
1.2%3/10

Operating margin of 1.2%

EMPG4 concerns · Avg: 3.3/10
Price/BookValuation
17.0x4/10

Trading at 17.0x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$143.05M3/10

Smaller company, higher risk/reward

P/E RatioValuation
192.9x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : CAH

The strongest argument for CAH centers on Altman Z-Score, Revenue Growth. Revenue growth of 18.8% demonstrates continued momentum. PEG of 1.33 suggests the stock is reasonably priced for its growth.

Bull Case : EMPG

The strongest argument for EMPG centers on Return on Equity, Operating Margin, Revenue Growth. Revenue growth of 141.6% demonstrates continued momentum.

Bear Case : CAH

The primary concerns for CAH are P/E Ratio, Return on Equity, Profit Margin. Thin 0.7% margins leave little buffer for downturns.

Bear Case : EMPG

The primary concerns for EMPG are Price/Book, EPS Growth, Market Cap. A P/E of 192.9x leaves little room for execution misses.

Key Dynamics to Monitor

EMPG is growing revenue faster at 141.6% — sustainability is the question.

CAH generates stronger free cash flow (555M), providing more financial flexibility.

Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CAH scores higher overall (53/100 vs 47/100) and 18.8% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cardinal Health Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Cardinal Health, Inc. is an American multinational health care services company.

Visit Website →

Empro Group Inc. Ordinary shares

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Empro Group Inc., through its subsidiary, sells healthcare and beauty products in Malaysia and internationally. The company is headquartered in Shah Alam, Malaysia.

Visit Website →

Want to dig deeper into these stocks?